Cryogel 3D Scaffolds for Controlled Porosity and Cell Seeding
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current 3D scaffold manufacturing methods face challenges in achieving porosity and spatial control of cell distribution, requiring sterile environments, compromising material properties, and hindering vascularization, while also being difficult to deliver minimally invasively.
Innovation Solution
The method involves additive manufacturing of cryogel scaffolds using a refrigerated stage for controlled cryogelation, allowing for the creation of multicompartment scaffolds with varying porosity and compressibility, enabling precise cell seeding and minimally invasive delivery through syringe needles, by modulating temperature and polymerization rates to achieve robust and interconnected structures.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If cells are mixed directly with scaffold precursors during 3D printing, then spatial control of cell position is improved, but sterile environment requirements and biohazard protection increase manufacturing complexity and cost
Solution Approach 1:
The invention separates the scaffold manufacturing process from cell seeding. The scaffold is printed first without cells, allowing standard manufacturing conditions, then cells are seeded separately into the finished scaffold. This segmentation eliminates the need for sterile environments during printing while maintaining spatial control through the scaffold's porous structure and subsequent cell migration.
Solution Approach 2:
The scaffold structure is prepared in advance with specific porous architectures and geometric features that pre-determine cell positioning. By creating the scaffold framework first with controlled porosity and interconnected channels, the system enables cells to self-organize and migrate to appropriate locations without requiring sterile handling during the printing process.
2Manufacturing precision
If cells and scaffolds are printed simultaneously, then cell position control is improved, but scaffold porosity is reduced which slows vascularization
Solution Approach 1:
The invention divides the manufacturing process into two independent stages: scaffold fabrication and cell seeding. This allows the scaffold to be printed with optimized porous structures using sacrificial materials or space-consuming support structures that would be incompatible with cell-containing inks. The high porosity scaffold is then separately populated with cells through seeding protocols.
Solution Approach 2:
The invention employs porous scaffold materials and structures with controlled pore sizes, interconnectivity, and hierarchical architectures. These porous features are created using techniques such as sacrificial ink removal, foam templates, or direct porous material deposition, enabling both high porosity for vascularization and subsequent cell seeding capabilities.
3Quantity of substance
If sacrificial materials are used to create porous scaffolds, then porosity is improved, but the manufacturing process complexity increases
Solution Approach 1:
The invention uses sacrificial materials (such as water, ice, or removable support structures) that are intentionally deposited during printing to create porous spaces, then systematically removed through washing, melting, or dissolution processes. This discarding of sacrificial materials creates the desired porous architecture while the manufacturing process remains relatively simple and additive.
4Ease of operation
If scaffolds are made highly compressible for minimally invasive delivery, then ease of delivery is improved, but structural strength is reduced
Solution Approach 1:
The invention creates scaffolds with dynamic mechanical properties that are highly compressible during delivery but regain structural integrity after implantation. This is achieved through shape-memory materials, superelastic polymers, or reversible crosslinking mechanisms that allow the scaffold to be compressed into a small volume for injection through needles, then automatically recover its original porous three-dimensional structure at the implantation site.
Solution Approach 2:
The invention utilizes materials whose mechanical properties can be changed through parameter variations such as temperature, pH, or ionic strength. For example, thermoresponsive hydrogels that are liquid at low temperatures for injection but gel at body temperature, or pH-responsive materials that change stiffness in response to the implantation environment, enabling both easy delivery and adequate structural strength.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach results in highly porous, reversibly compressible scaffolds that can be deeply seeded with cells, facilitating rapid vascularization and functional tissue development, while maintaining cell viability and biocompatibility, and can be sterilized effectively for clinical use.
Implementation Method 1
providing a first frozen polymeric layer on a refrigerated support kept at subzero temperature
Implementation Method 2
placing the produced cryogel at a temperature above 0° C.
Data Source
AI summary
A method of producing a cryogel-based multicompartment 3D scaffold is herein disclosed. The method comprises the steps of: a) providing a first frozen polymeric layer on a refrigerated support kept at subzero temperature; b) providing subsequent polymeric layers to obtain a stack of polymeric layers by possibly modulating the subzero temperature of the refrigerated support; c) optionally incubating the final polymeric structure at subzero temperature; and d) placing the produced cryogel at a temperature above 0° C., wherein each subsequent layer i) is deposited on the previous one after freezing of this latter; ii) is deposited on the previous one before the complete polymerization of this latter; and iii) is deposited with a temperature higher than the freezing temperature of the previously deposited layer. Cryogel scaffolds obtained from said method are also disclosed.